Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-3 of 3
Keywords: mononuclear cell
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Haiyan Wu, Anton J. M. Roks, Frank P. J. Leijten, Ingrid M Garrelds, Usha M. Musterd-Bhaggoe, Antoon J. van den Bogaerdt, Moniek P. M. de Maat, Maarten L. Simoons, A. H. Jan Danser, Hisko Oeseburg
Journal:
Clinical Science
Clin Sci (Lond) (2014) 126 (6): 441–449.
Published: 25 November 2013
... the effect of this polymorphism on B 1 -receptor-mediated coronary artery dilation and peripheral blood mononuclear cell activation. Vasorelaxant responses of human coronary microarteries from subjects without coronary disease to des-Arg 9 -bradykinin and to bradykinin were studied in organ bath experiments...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2005) 109 (6): 483–492.
Published: 23 November 2005
... mononuclear cell Congestive heart failure is a leading cause of death in industrialized nations. In the U.S. alone, over 500000 new cases are diagnosed yearly [ 1 ]. The mainstay of treatment is lifestyle modification and pharmacotherapy, including treatment with β-blockers and ACE inhibitors...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2002) 103 (s2002): 340S–344S.
Published: 01 September 2002
..., mononuclear cells and neutrophils in broncho-alveolar lavage fluid 4h after injection. Bosentan and Ro 46-8443 (at doses of 30 and 10mg·kg -1 respectively) inhibited the neutrophil infiltration induced by oleic acid by approx. 80%. None of the antagonists modified control (basal) pulmonary microvascular...